BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29208618)

  • 1. Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol.
    Atkins C; Fordham R; Clark AB; Stockl A; Jones AP; Wilson AM
    BMJ Open; 2017 Dec; 7(12):e018532. PubMed ID: 29208618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial.
    Atkins C; Jones A; Clark AB; Stockl A; Fordham R; Wilson AM
    BMJ Open Respir Res; 2021 May; 8(1):. PubMed ID: 34020962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
    Lower EE; Harman S; Baughman RP
    Chest; 2008 May; 133(5):1189-95. PubMed ID: 18263672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.
    Moraska AR; Sood A; Dakhil SR; Sloan JA; Barton D; Atherton PJ; Suh JJ; Griffin PC; Johnson DB; Ali A; Silberstein PT; Duane SF; Loprinzi CL
    J Clin Oncol; 2010 Aug; 28(23):3673-9. PubMed ID: 20625123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosis.
    Wagner MT; Marion SD; Judson MA
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):235. PubMed ID: 16315789
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.
    Richard PO; Fleshner NE; Bhatt JR; Hersey KM; Chahin R; Alibhai SM
    BJU Int; 2015 Nov; 116(5):744-52. PubMed ID: 24684534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved cancer-related fatigue in a randomised clinical trial: methylphenidate no better than placebo.
    Centeno C; Rojí R; Portela MA; De Santiago A; Cuervo MA; Ramos D; Gandara A; Salgado E; Gagnon B; Sanz A
    BMJ Support Palliat Care; 2022 Jun; 12(2):226-234. PubMed ID: 33168668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
    Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
    J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing fatigue in sarcoidosis - A systematic review of the evidence.
    Atkins C; Wilson AM
    Chron Respir Dis; 2017 May; 14(2):161-173. PubMed ID: 27507833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
    J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
    Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
    Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.
    Bruera E; Yennurajalingam S; Palmer JL; Perez-Cruz PE; Frisbee-Hume S; Allo JA; Williams JL; Cohen MZ
    J Clin Oncol; 2013 Jul; 31(19):2421-7. PubMed ID: 23690414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
    Mendonça DA; Menezes K; Jog MS
    Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
    Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
    J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.
    Pride NA; Barton B; Hutchins P; Coghill DR; Korgaonkar MS; Hearps SJC; Rouel M; Malarbi S; North KN; Payne JM
    BMJ Open; 2018 Aug; 8(8):e021800. PubMed ID: 30166301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
    Sarhill N; Walsh D; Nelson KA; Homsi J; LeGrand S; Davis MP
    Am J Hosp Palliat Care; 2001; 18(3):187-92. PubMed ID: 11406895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer.
    Mar Fan HG; Clemons M; Xu W; Chemerynsky I; Breunis H; Braganza S; Tannock IF
    Support Care Cancer; 2008 Jun; 16(6):577-83. PubMed ID: 17972110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
    Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.